Skip to main content

Bellevue Group AG

13F filer · CIK 0001674546
Reported Aug 14, 2026
Net buyer this quarter
13F portfolio value$4.75BU.S. long equity reported on 13F
Positions14717 new · 24 closed
Net flow last quarter+$33MBuys minus sells
Top 10 positions weight42.9%Concentration

Holdings

13F · last 4 quarters free
Scroll for earlier quarters
CompanyValue% of portfolio% of companyPOSITION CHANGE qoq %First reported
Q2 2026Reported Aug 14, 2026147 positions
AMGNAmgen Inc$308M6.49%0.16%+188.3%Q1 2016
VRTXVertex Pharmaceuticals Inc / Ma$287M6.05%0.23%-15.1%Q1 2016
ARGXArgenx SE$279M5.88%0.49%-3.8%Q4 2018
GILDGilead Sciences, Inc.$273M5.74%0.17%+84.5%Q1 2016
RVMDRevolution Medicines, Inc.$196M4.13%0.49%-32.1%Q4 2020
ORKAOruka Therapeutics, Inc.$158M3.32%2.71%+226.9%Q1 2026
INSMINSMED Inc$149M3.13%0.64%+13787.0%Q1 2018
SRRKScholar Rock Holding Corp$135M2.83%2.01%-31.7%Q2 2019
NUVLNuvalent, Inc.$130M2.74%33.66%Not reportedQ4 2025
VRDNViridian Therapeutics, Inc.\DE$124M2.60%5.94%+0.1%Q2 2022
RLAYRelay Therapeutics, Inc.$116M2.44%2.83%-20.6%Q3 2020
PCVXVaxcyte, Inc.$115M2.41%1.36%+65.6%Q2 2023
UTHRUNITED THERAPEUTICS Corp$102M2.15%0.44%+8976.3%Q1 2016
ISRGIntuitive Surgical Inc$101M2.13%0.07%-11.1%Q1 2016
REGNRegeneron Pharmaceuticals, Inc.$98.1M2.06%0.17%-43.6%Q1 2016
CRNXCrinetics Pharmaceuticals, Inc.$98M2.06%2.48%-20.1%Q4 2025
BBIOBridgeBio Pharma, Inc.$88.6M1.86%0.61%+4587.3%Q1 2023
IMCRImmunocore Holdings plc$88.5M1.86%5.42%-0.3%Q3 2023
ABTAbbott Laboratories$85.9M1.81%0.05%-17.8%Q1 2016
SYKStryker Corp$84.5M1.78%0.07%+23.6%Q1 2016
MDTMedtronic plc$77.8M1.64%0.08%+3.9%Q1 2016
IONSIonis Pharmaceuticals Inc$77.1M1.62%0.59%-46.5%Q1 2016
ELVNEnliven Therapeutics, Inc.$75.6M1.59%2.03%-35.8%Q1 2026
VERAVera Therapeutics, Inc.$73.4M1.54%2.38%0.0%Q4 2025
JBIOJade Biosciences, Inc.$67.9M1.43%4.81%-12.7%Q4 2025
EWEdwards Lifesciences Corp$66.9M1.41%0.13%-11.9%Q1 2016
RAREUltragenyx Pharmaceutical Inc.$66.2M1.39%2.01%-16.7%Q1 2016
UNHUnitedhealth Group Inc$62M1.30%0.02%+0.6%Q1 2016
DXCMDexcom Inc$55.4M1.17%0.22%+4.3%Q1 2016
CLDXCelldex Therapeutics, Inc.$44.7M0.94%1.53%Not reportedQ1 2016
AVLNAvalyn Pharma Inc.$44.4M0.94%3.05%NewQ2 2026
DMRADamora Therapeutics, Inc.$42.1M0.89%2.62%-29.6%Q1 2026
IRONDisc Medicine, Inc.$41M0.86%1.46%+21.9%Q1 2026
TMOThermo Fisher Scientific Inc.$40M0.84%0.02%+23.9%Q1 2016
BSXBoston Scientific Corp$37.9M0.80%0.06%-39.5%Q1 2016
LLYELI LILLY & Co$35.8M0.75%0.00%-11.9%Q1 2016
CGONCG Oncology, Inc.$35.1M0.74%0.56%Not reportedQ4 2025
IDXXIdexx Laboratories Inc$32.5M0.68%0.08%-30.7%Q2 2018
RMDResmed Inc$28.9M0.61%0.10%-7.0%Q1 2016
KRYSKrystal Biotech, Inc.$28.8M0.61%0.26%-83.9%Q4 2021
GLUEMonte Rosa Therapeutics, Inc.$28.8M0.61%1.40%-4.8%Q1 2026
DHRDanaher Corp$27.4M0.58%0.02%-28.9%Q4 2016
JNJJohnson & Johnson$26.2M0.55%0.00%-13.3%Q1 2016
SPTXSeaport Therapeutics, Inc.$23.9M0.50%2.05%NewQ2 2026
PVLAPalvella Therapeutics, Inc.$23.7M0.50%1.08%NewQ2 2026
ALGNAlign Technology Inc$23.6M0.50%0.20%Not reportedQ1 2017
ANNXAnnexon, Inc.$23.4M0.49%2.75%-20.5%Q1 2024
HUMHumana Inc$23.2M0.49%0.05%-9.5%Q1 2016
ELVElevance Health, Inc.$21.8M0.46%0.03%+7.5%Q1 2016
TNGXTango Therapeutics, Inc.$21.7M0.46%0.41%-71.1%Q4 2025
Q1 2026Reported May 15, 2026154 positions
VRTXVertex Pharmaceuticals Inc / Ma$304M7.25%0.27%+0.1%Q1 2016
ARGXArgenx SE$229M5.44%0.51%-32.2%Q4 2018
REGNRegeneron Pharmaceuticals, Inc.$215M5.12%0.30%+1900.8%Q1 2016
SRRKScholar Rock Holding Corp$176M4.19%3.01%-11.6%Q2 2019
GILDGilead Sciences, Inc.$163M3.88%0.09%+2117.7%Q1 2016
RVMDRevolution Medicines, Inc.$150M3.57%0.77%-69.2%Q4 2020
IONSIonis Pharmaceuticals Inc$137M3.25%1.10%-62.1%Q1 2016
ISRGIntuitive Surgical Inc$132M3.14%0.08%-11.0%Q1 2016
VRDNViridian Therapeutics, Inc.\DE$132M3.13%6.56%+54.3%Q2 2022
KRYSKrystal Biotech, Inc.$124M2.96%1.64%+17.4%Q4 2021
CRNXCrinetics Pharmaceuticals, Inc.$119M2.84%3.11%+81088.1%Q4 2025
ABTAbbott Laboratories$118M2.81%0.07%-12.6%Q1 2016
NUVLNuvalent, Inc.$108M2.57%33.66%+1.5%Q4 2025
AMGNAmgen Inc$104M2.47%0.05%+1497.5%Q1 2016
BSXBoston Scientific Corp$92M2.19%0.10%-5.9%Q1 2016
ELVNEnliven Therapeutics, Inc.$91M2.17%3.81%NewQ1 2026
IMCRImmunocore Holdings plc$84.3M2.01%5.50%Not reportedQ3 2023
MDTMedtronic plc$83M1.97%0.07%+24.9%Q1 2016
ALNYAlnylam Pharmaceuticals, Inc.$77.6M1.85%0.18%-47.4%Q1 2016
RLAYRelay Therapeutics, Inc.$77.6M1.85%4.12%-6.6%Q3 2020
SYKStryker Corp$71.4M1.70%0.06%-39.8%Q1 2016
PCVXVaxcyte, Inc.$69.2M1.65%0.83%Not reportedQ2 2023
VERAVera Therapeutics, Inc.$68.8M1.64%2.68%+0.7%Q4 2025
EWEdwards Lifesciences Corp$67.2M1.60%0.15%-19.5%Q1 2016
DMRADamora Therapeutics, Inc.$59.5M1.42%3.81%NewQ1 2026
TNGXTango Therapeutics, Inc.$50.2M1.19%1.66%-38.9%Q4 2025
IDXXIdexx Laboratories Inc$50.1M1.19%0.11%-5.7%Q2 2018
RAREUltragenyx Pharmaceutical Inc.$49.9M1.19%2.42%+92148.1%Q1 2016
DXCMDexcom Inc$49.5M1.18%0.20%-6.9%Q1 2016
JBIOJade Biosciences, Inc.$49.2M1.17%7.10%+4.8%Q4 2025
EWTXEdgewise Therapeutics, Inc.$48.1M1.15%1.42%Not reportedQ2 2024
UNHUnitedhealth Group Inc$40.1M0.95%0.02%-15.4%Q1 2016
DHRDanaher Corp$38.3M0.91%0.03%+3.9%Q4 2016
CLDXCelldex Therapeutics, Inc.$38.1M0.91%1.80%-66.8%Q1 2016
RMDResmed Inc$35.8M0.85%0.11%-1.2%Q1 2016
PODDInsulet Corp$34.3M0.82%0.23%-12.3%Q1 2016
TMOThermo Fisher Scientific Inc.$31.7M0.75%0.02%-1.0%Q1 2016
LLYELI LILLY & Co$31.2M0.74%0.00%-0.2%Q1 2016
GEHCGE HealthCare Technologies Inc.$29.7M0.71%0.09%-1.8%Q3 2023
IRONDisc Medicine, Inc.$29.4M0.70%1.20%NewQ1 2026
JNJJohnson & Johnson$29.1M0.69%0.00%-6.1%Q1 2016
ANNXAnnexon, Inc.$28.6M0.68%3.45%Not reportedQ1 2024
CICigna Group$26.2M0.62%0.04%-10.7%Q1 2016
ORKAOruka Therapeutics, Inc.$24.9M0.59%1.01%NewQ1 2026
MRKMerck & Co., Inc.$24.9M0.59%0.01%+124.3%Q1 2016
ALGNAlign Technology Inc$23.9M0.57%0.20%-1.3%Q1 2017
STESTERIS plc$22.1M0.53%0.10%-1.8%Q1 2024
GMEDGlobus Medical Inc$21.3M0.51%0.18%-5.9%Q1 2016
GLUEMonte Rosa Therapeutics, Inc.$20.6M0.49%1.48%NewQ1 2026
ABBVAbbVie Inc.$20.3M0.48%0.01%-30.6%Q1 2016
Q4 2025Reported Feb 17, 2026174 positions
RVMDRevolution Medicines, Inc.$399M7.56%2.54%-10.2%Q4 2020
ARGXArgenx SE$388M7.36%0.75%-15.5%Q4 2018
IONSIonis Pharmaceuticals Inc$380M7.20%2.94%-23.1%Q1 2016
VRTXVertex Pharmaceuticals Inc / Ma$309M5.85%0.27%+34.7%Q1 2016
NBIXNeurocrine Biosciences Inc$242M4.58%1.70%-3.4%Q1 2016
RNAMAvidity Biosciences, Inc.$190M3.60%1.74%+22.2%Q3 2025
ISRGIntuitive Surgical Inc$182M3.46%0.09%-7.6%Q1 2016
SRRKScholar Rock Holding Corp$179M3.39%3.74%+25.0%Q2 2019
ALNYAlnylam Pharmaceuticals, Inc.$177M3.36%0.34%-0.1%Q1 2016
ABTAbbott Laboratories$165M3.13%0.08%-10.9%Q1 2016
FOLDAmicus Therapeutics, Inc.$153M2.90%3.45%Not reportedQ1 2019
BSXBoston Scientific Corp$149M2.82%0.11%-6.0%Q1 2016
VRDNViridian Therapeutics, Inc.\DE$136M2.57%4.28%Not reportedQ2 2022
SYKStryker Corp$127M2.40%0.09%-20.1%Q1 2016
NUVLNuvalent, Inc.$104M1.98%33.15%NewQ4 2025
KRYSKrystal Biotech, Inc.$101M1.92%1.41%+31174.6%Q4 2021
CLDXCelldex Therapeutics, Inc.$98.3M1.86%5.44%+1.7%Q1 2016
IMCRImmunocore Holdings plc$97.1M1.84%5.52%Not reportedQ3 2023
EWEdwards Lifesciences Corp$88.9M1.69%0.18%+16.3%Q1 2016
VERAVera Therapeutics, Inc.$86M1.63%2.66%NewQ4 2025
MDTMedtronic plc$73.6M1.40%0.06%+0.9%Q1 2016
RLAYRelay Therapeutics, Inc.$70.6M1.34%4.80%0.0%Q3 2020
IDXXIdexx Laboratories Inc$64M1.21%0.12%+23.4%Q2 2018
UNHUnitedhealth Group Inc$57.8M1.10%0.02%+3.0%Q1 2016
DXCMDexcom Inc$56.2M1.07%0.22%+7.8%Q1 2016
PODDInsulet Corp$53.1M1.01%0.27%-11.9%Q1 2016
BDXBecton Dickinson & Co$51.6M0.98%0.09%-10.5%Q1 2016
JBIOJade Biosciences, Inc.$51.6M0.98%6.77%NewQ4 2025
DHRDanaher Corp$44.6M0.84%0.03%+18.8%Q4 2016
PENPenumbra Inc$42.1M0.80%0.35%-7.8%Q1 2016
RMDResmed Inc$38.8M0.74%0.11%-2.2%Q1 2016
EWTXEdgewise Therapeutics, Inc.$37.9M0.72%1.44%-44.9%Q2 2024
TMOThermo Fisher Scientific Inc.$37.7M0.71%0.02%-38.7%Q1 2016
MAZEMaze Therapeutics, Inc.$36.8M0.70%1.80%NewQ4 2025
LLYELI LILLY & Co$36.5M0.69%0.00%-16.1%Q1 2016
GEHCGE HealthCare Technologies Inc.$34.8M0.66%0.09%-8.3%Q3 2023
TNGXTango Therapeutics, Inc.$34.8M0.66%2.89%NewQ4 2025
ABBVAbbVie Inc.$30.8M0.58%0.01%-21.1%Q1 2016
CICigna Group$30.3M0.57%0.04%-10.2%Q1 2016
GKOSGLAUKOS Corp$29.6M0.56%0.46%+368.4%Q4 2016
JNJJohnson & Johnson$26.2M0.50%0.01%+69.5%Q1 2016
ANNXAnnexon, Inc.$25.9M0.49%3.45%Not reportedQ1 2024
STESTERIS plc$25.8M0.49%0.10%-13.9%Q1 2024
WVEWave Life Sciences, Inc.$25.3M0.48%0.79%-63.6%Q2 2019
ELVElevance Health, Inc.$24.4M0.46%0.03%-33.7%Q1 2016
COOCooper Companies, Inc.$23.9M0.45%0.15%-0.1%Q1 2016
GMEDGlobus Medical Inc$22.9M0.43%0.20%-19.6%Q1 2016
ALGNAlign Technology Inc$22.1M0.42%0.20%-2.2%Q1 2017
ZBHZimmer Biomet Holdings, Inc.$21.5M0.41%0.12%-2.7%Q1 2016
MCKMckesson Corp$20.6M0.39%0.02%-33.9%Q1 2016
Q3 2025Reported Nov 14, 2025146 positions
IONSIonis Pharmaceuticals Inc$409M8.49%3.88%-20.5%Q1 2016
ARGXArgenx SE$403M8.37%0.90%-4.3%Q4 2018
RVMDRevolution Medicines, Inc.$260M5.41%2.94%+21.7%Q4 2020
NBIXNeurocrine Biosciences Inc$248M5.14%1.77%-3.1%Q1 2016
ALNYAlnylam Pharmaceuticals, Inc.$204M4.23%0.34%-34.0%Q1 2016
VRTXVertex Pharmaceuticals Inc / Ma$198M4.12%0.20%+14.5%Q1 2016
ABTAbbott Laboratories$198M4.11%0.09%-5.5%Q1 2016
SYKStryker Corp$167M3.46%0.12%-15.7%Q1 2016
BSXBoston Scientific Corp$162M3.37%0.11%-6.0%Q1 2016
ISRGIntuitive Surgical Inc$156M3.24%0.10%-8.0%Q1 2016
AGIOAgios Pharmaceuticals, Inc.$149M3.10%6.37%+3.5%Q1 2016
INCYIncyte Corp$122M2.54%0.73%-8.3%Q1 2016
SRRKScholar Rock Holding Corp$121M2.51%3.27%+10.1%Q2 2019
AKROAkero Therapeutics, Inc.$113M2.36%2.98%+20.4%Q3 2022
IMCRImmunocore Holdings plc$102M2.11%5.54%+14.5%Q3 2023
RNAMAvidity Biosciences, Inc.$93.8M1.95%1.47%NewQ3 2025
CLDXCelldex Therapeutics, Inc.$92M1.91%5.35%+7.6%Q1 2016
MDTMedtronic plc$72.4M1.50%0.06%-17.5%Q1 2016
BEAMBeam Therapeutics Inc.$70.1M1.46%2.85%Not reportedQ4 2020
EWEdwards Lifesciences Corp$69.7M1.45%0.15%+0.9%Q1 2016
PODDInsulet Corp$65.5M1.36%0.30%-3.2%Q1 2016
UNHUnitedhealth Group Inc$58.7M1.22%0.02%+19.5%Q1 2016
BDXBecton Dickinson & Co$55.6M1.15%0.10%-6.3%Q1 2016
DXCMDexcom Inc$52.9M1.10%0.20%-8.7%Q1 2016
TMOThermo Fisher Scientific Inc.$51.5M1.07%0.03%-6.5%Q1 2016
IDXXIdexx Laboratories Inc$48.9M1.02%0.10%+0.1%Q2 2018
RMDResmed Inc$45.1M0.94%0.11%-0.6%Q1 2016
EWTXEdgewise Therapeutics, Inc.$45M0.94%2.62%Not reportedQ2 2024
RLAYRelay Therapeutics, Inc.$43.6M0.91%4.83%+1.4%Q3 2020
BHVNBiohaven Ltd.$42.1M0.87%2.65%Not reportedQ4 2019
ABBVAbbVie Inc.$39.6M0.82%0.01%+7.0%Q1 2016
PENPenumbra Inc$37.2M0.77%0.38%-15.6%Q1 2016
CICigna Group$35.3M0.73%0.05%+10.6%Q1 2016
GEHCGE HealthCare Technologies Inc.$34.8M0.72%0.10%-10.2%Q3 2023
ELVElevance Health, Inc.$33.9M0.70%0.05%+27.9%Q1 2016
DHRDanaher Corp$32.5M0.68%0.02%+19.8%Q4 2016
LLYELI LILLY & Co$30.9M0.64%0.00%-1.0%Q1 2016
WVEWave Life Sciences, Inc.$30M0.62%2.55%Not reportedQ2 2019
MCKMckesson Corp$29.3M0.61%0.03%-6.2%Q1 2016
STESTERIS plc$29.2M0.61%0.12%+7.5%Q1 2024
VEEVVeeva Systems Inc$29M0.60%0.06%-14.0%Q2 2018
HCAHCA Healthcare, Inc.$28M0.58%0.03%-33.8%Q1 2016
ZBHZimmer Biomet Holdings, Inc.$24.2M0.50%0.12%-8.4%Q1 2016
COOCooper Companies, Inc.$20M0.42%0.15%-17.9%Q1 2016
HUMHumana Inc$19.9M0.41%0.06%+55.3%Q1 2016
GMEDGlobus Medical Inc$18.7M0.39%0.24%-1.7%Q1 2016
ALGNAlign Technology Inc$18.1M0.38%0.20%-4.1%Q1 2017
MOHMolina Healthcare, Inc.$17.4M0.36%0.18%+22.9%Q3 2016
HOLXHologic Inc$16.7M0.35%0.11%Not reportedQ1 2016
MGNXMacrogenics Inc$16.7M0.35%15.68%Not reportedQ1 2016
Premium opens every quarter this fund has filed

Not investment advice. We make every effort to keep the information on SpoorBase accurate, but errors may occur. SpoorBase does not guarantee the accuracy or completeness of any data, and any use of the information is at the user’s sole responsibility. Valuation multiples are calculated by SpoorBase and may contain errors. See Disclosures. © 2026 SpoorBase. All rights reserved.